MSCLF

Satellos Bioscience Inc.

USD

Set alert

Price alert · MSCLF

All alert types
6.25 USD 0.00 0.00%
As of Apr 8, 2026
5.77 Day range 6.39
0.88 52-week range 12.50
YTD
+6.29%
1 year
-5.16%
Open
5.79
Prev close
6.25
Mkt cap
96.62M
Vol
62.40K
Avg vol
12.13K
EPS
2.57
P/E
2.43
More statistics
Low
5.77
High
6.39

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for MSCLF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

14.67 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.3×
FY 2016: -25.1×FY 2017: -45.3×FY 2018: -25.4×FY 2019: -50.0×FY 2020: -25.8×FY 2021: -1.6×FY 2022: -0.7×FY 2023: -3037×FY 2024: -3394×FY 2025: -0.3×
FY 2016 5y median -1.6× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.3×
FY 2016: 18.6×FY 2017: 34.7×FY 2018: -70.6×FY 2019: 153×FY 2020: -223×FY 2021: 2.4×FY 2022: 2.5×FY 2023: 1.2×FY 2024: 1.4×FY 2025: 0.3×
FY 2016 5y median 1.4× FY 2025
P/FCF -0.3×
FY 2016: -32.3×FY 2017: 0.0×FY 2018: -39.8×FY 2019: -45.0×FY 2020: -24.6×FY 2021: -4.9×FY 2022: -1.5×FY 2023: -3.3×FY 2024: -3.8×FY 2025: -0.3×
FY 2016 5y median -3.3× FY 2025
EV/EBITDA 0.1×
FY 2016: -27.9×FY 2017: -30.1×FY 2018: -25.9×FY 2019: -45.4×FY 2020: -25.6×FY 2021: -4.3×FY 2022: -0.8×FY 2023: -3126×FY 2024: -5197×FY 2025: 0.1×
FY 2016 5y median -4.3× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -330.0%
FY 2016: -3.1%FY 2017: 0.0%FY 2018: -2.5%FY 2019: -2.2%FY 2020: -4.1%FY 2021: -20.4%FY 2022: -68.9%FY 2023: -29.9%FY 2024: -26.0%FY 2025: -330.0%
FY 2016 5y median -29.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -89.5%
FY 2016: -64.4%FY 2017: -113.8%FY 2018: 272.6%FY 2019: -293.4%FY 2020: 858.7%FY 2021: -147.9%FY 2022: -336.1%FY 2023: -0.0%FY 2024: -0.0%FY 2025: -89.5%
FY 2016 5y median -89.5% FY 2025
ROIC -95.2%
FY 2016: -53.2%FY 2017: -135.5%FY 2018: 352.6%FY 2019: -293.7%FY 2020: -304.9%FY 2021: -63.4%FY 2022: -249.6%FY 2023: -0.0%FY 2024: -0.0%FY 2025: -95.2%
FY 2016 5y median -63.4% FY 2025
ROA -78.0%
FY 2016: -60.8%FY 2017: -90.0%FY 2018: -955.6%FY 2019: -132.0%FY 2020: -139.8%FY 2021: -123.2%FY 2022: -182.7%FY 2023: -0.0%FY 2024: -0.0%FY 2025: -78.0%
FY 2016 5y median -78.0% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -95048.9%
FY 2016: 43.8%FY 2017: -20.5%FY 2018: -46.8%FY 2019: -0.5%FY 2020: -25.7%FY 2021: -139.7%FY 2022: -26.5%FY 2023: 99.8%FY 2024: -79.8%FY 2025: -95048.9%
FY 2016 FY 2025
EPS (diluted) -679900.0%
FY 2016: -2.5%FY 2017: 51.2%FY 2018: -105.0%FY 2019: 19.5%FY 2020: -75.8%FY 2021: -1224.1%FY 2022: 50.5%FY 2023: 100.0%FY 2024: -76.5%FY 2025: -679900.0%
FY 2016 FY 2025
Free Cash Flow 5.5%
FY 2016: 56.4%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -103.2%FY 2020: 26.0%FY 2021: -203.7%FY 2022: -13.4%FY 2023: -154.0%FY 2024: -72.1%FY 2025: 5.5%
FY 2016 FY 2025

Financial Health

Current Ratio 7.8×
FY 2016: 17.5×FY 2017: 4.8×FY 2018: 0.2×FY 2019: 1.8×FY 2020: 5.1×FY 2021: 2.6×FY 2022: 0.8×FY 2023: 11.1×FY 2024: 14.2×FY 2025: 7.8×
FY 2016 5y median 7.8× FY 2025
Quick Ratio 7.8×
FY 2016: 17.5×FY 2017: 4.8×FY 2018: 0.2×FY 2019: 1.8×FY 2020: 5.1×FY 2021: 2.6×FY 2022: 0.8×FY 2023: 11.1×FY 2024: 14.2×FY 2025: 7.8×
FY 2016 5y median 7.8× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -5.9×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2016: 1.6×FY 2017: 0.9×FY 2018: 0.0×FY 2019: 0.4×FY 2020: -0.2×FY 2021: 1.1×FY 2022: 0.2×FY 2023: 2606×FY 2024: 7835×FY 2025: 0.4×
FY 2016 5y median 1.1× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -120×FY 2021: -6.7×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31